The big US pharmas know how good TLX and the revenue and product pipeline. Either lob in a bid for the conmpany now around $8bn (current maket cap $5bn) or TLX will be $20bn in two years.
Nasdaq listed coimg, and will be in the ASX100 next rebalance (and funds will have to buy).
it ain’t even nearly overvalued. Will just continue it’s stready climb. As I, and others have said, it’s the best growth story on the ASX.
Ann: Telix Q1 2024 Revenue and Business Update, page-107
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.48 |
Change
0.030(0.15%) |
Mkt cap ! $6.854B | |||
| Open | High | Low | Value | Volume |
| $20.35 | $20.83 | $20.30 | $10.68M | 520.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1586 | $20.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.58 | 898 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |